Phase 2 PTSD Trial, Recruiting NCT07569159 Sponsor: Sunstone Medical Condition: PTSD
Back to Ptsd

Phase 2 PTSD Trial, Recruiting

NCT07569159
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have served in the military (veterans) and are at least 18 years old
  • People who are able to swallow pills
  • People who are able to complete all required questionnaires and assessments without assistance or changes to the standard format, and who can attend all required study visits
  • People who can speak and read English confidently

Who may not be able to join:

  • People who have a condition that affects their ability to eat or absorb food through digestion
  • People who are not able to give full, informed agreement to take part in the study
  • People who have had serious thoughts of suicide — including having both a plan and an intention to act on it — in the past 3 months (as measured by a standard assessment tool called the C-SSRS)
  • People who have heart or cardiovascular disease, such as blocked heart arteries or chronic heart failure
  • People who have a current or past diagnosis of schizophrenia, schizoaffective disorder, any psychotic disorder, major depression with psychotic features, bipolar disorder type 1, or a personality disorder
  • People who are pregnant, breastfeeding, or capable of becoming pregnant and not using effective contraception if sexually active with a biological male partner
  • People who are currently enrolled in another clinical trial involving an experimental drug or device, or who have taken part in one within the past 30 days before screening

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Manish Agarwal, Sunstone Medical, PC

Phone: (301) 750-3401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Sunstone Medical
Registry
ClinicalTrials.gov
Start date
30 June 2026
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety and Tolerability; C-SSRS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov